Literature DB >> 17060338

Ratio measures in leading medical journals: structured review of accessibility of underlying absolute risks.

Lisa M Schwartz1, Steven Woloshin, Evan L Dvorin, H Gilbert Welch.   

Abstract

OBJECTIVE: To examine the accessibility of absolute risk in articles reporting ratio measures in leading medical journals.
DESIGN: Structured review of abstracts presenting ratio measures.
SETTING: Articles published between 1 June 2003 and 1 May 2004 in Annals of Internal Medicine, BMJ, Journal of the American Medical Association, Journal of the National Cancer Institute, Lancet, and New England Journal of Medicine. PARTICIPANTS: 222 articles based on study designs in which absolute risks were directly calculable (61 randomised trials, 161 cohort studies). MAIN OUTCOME MEASURE: Accessibility of the absolute risks underlying the first ratio measure in the abstract.
RESULTS: 68% of articles (150/222) failed to report the underlying absolute risks for the first ratio measure in the abstract (range 55-81% across the journals). Among these articles, about half did report the underlying absolute risks elsewhere in the article (text, table, or figure) but half did not report them anywhere. Absolute risks were more likely to be reported in the abstract for randomised trials compared with cohort studies (62% v 21%; relative risk 3.0, 95% confidence interval 2.1 to 4.2) and for studies reporting crude compared with adjusted ratio measures (62% v 21%; relative risk 3.0, 2.1 to 4.3).
CONCLUSION: Absolute risks are often not easily accessible in articles reporting ratio measures and sometimes are missing altogether-this lack of accessibility can easily exaggerate readers' perceptions of benefit or harm.

Entities:  

Mesh:

Year:  2006        PMID: 17060338      PMCID: PMC1702463          DOI: 10.1136/bmj.38985.564317.7C

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  10 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

2.  Absolutely relative: how research results are summarized can affect treatment decisions.

Authors:  L Forrow; W C Taylor; R M Arnold
Journal:  Am J Med       Date:  1992-02       Impact factor: 4.965

3.  What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes.

Authors:  J Zhang; K F Yu
Journal:  JAMA       Date:  1998-11-18       Impact factor: 56.272

4.  Abstruse comparisons: the problems of numerical contrasts of two groups.

Authors:  B Yueh; A R Feinstein
Journal:  J Clin Epidemiol       Date:  1999-01       Impact factor: 6.437

5.  Evidence based purchasing: understanding results of clinical trials and systematic reviews.

Authors:  T Fahey; S Griffiths; T J Peters
Journal:  BMJ       Date:  1995-10-21

6.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

7.  The role of numeracy in understanding the benefit of screening mammography.

Authors:  L M Schwartz; S Woloshin; W C Black; H G Welch
Journal:  Ann Intern Med       Date:  1997-12-01       Impact factor: 25.391

8.  The framing effect of relative and absolute risk.

Authors:  D J Malenka; J A Baron; S Johansen; J W Wahrenberger; J M Ross
Journal:  J Gen Intern Med       Date:  1993-10       Impact factor: 5.128

9.  Measured enthusiasm: does the method of reporting trial results alter perceptions of therapeutic effectiveness?

Authors:  C D Naylor; E Chen; B Strauss
Journal:  Ann Intern Med       Date:  1992-12-01       Impact factor: 25.391

10.  Communicating the benefits of chronic preventive therapy: does the format of efficacy data determine patients' acceptance of treatment?

Authors:  J E Hux; C D Naylor
Journal:  Med Decis Making       Date:  1995 Apr-Jun       Impact factor: 2.583

  10 in total
  29 in total

1.  Implicit value judgments in the measurement of health inequalities.

Authors:  Sam Harper; Nicholas B King; Stephen C Meersman; Marsha E Reichman; Nancy Breen; John Lynch
Journal:  Milbank Q       Date:  2010-03       Impact factor: 4.911

2.  Type D personality is not associated with coronary heart disease risk in a North American sample of retirement-aged adults.

Authors:  Noel C Larson; Steven D Barger; Sumner J Sydeman
Journal:  Int J Behav Med       Date:  2013-06

Review 3.  Do we learn the right things from clinical trials?

Authors:  Silvio Garattini; Vittorio Bertele'
Journal:  Eur J Clin Pharmacol       Date:  2008-01-29       Impact factor: 2.953

4.  Promoting healthy skepticism in the news: helping journalists get it right.

Authors:  Steven Woloshin; Lisa M Schwartz; Barnett S Kramer
Journal:  J Natl Cancer Inst       Date:  2009-11-20       Impact factor: 13.506

5.  Endpoint selection and relative (versus absolute) risk reporting in published medication trials.

Authors:  Michael Hochman; Danny McCormick
Journal:  J Gen Intern Med       Date:  2011-08-13       Impact factor: 5.128

6.  Outcomes, outcomes, every where, nor any stop to think?

Authors:  Colin P West
Journal:  J Gen Intern Med       Date:  2011-11       Impact factor: 5.128

7.  Surrogate endpoint analysis: an exercise in extrapolation.

Authors:  Stuart G Baker; Barnett S Kramer
Journal:  J Natl Cancer Inst       Date:  2012-12-21       Impact factor: 13.506

8.  Evaluating Markers for Guiding Treatment.

Authors:  Stuart G Baker; Marco Bonetti
Journal:  J Natl Cancer Inst       Date:  2016-05-18       Impact factor: 13.506

9.  Risk factor modification and projections of absolute breast cancer risk.

Authors:  Elisabetta Petracci; Adriano Decarli; Catherine Schairer; Ruth M Pfeiffer; David Pee; Giovanna Masala; Domenico Palli; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2011-06-24       Impact factor: 13.506

10.  Characteristics of medical research news reported on front pages of newspapers.

Authors:  William Yuk Yeu Lai; Trevor Lane
Journal:  PLoS One       Date:  2009-07-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.